ArticleBiotechnology reports (Amsterdam, Netherlands)2026
Dissection of MAPK and NF-κB p65 signaling dynamics underlying LPS tolerance in macrophages at the single-cell level.
Article in Biotechnology reports (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MAPK and NF-κB pathways regulate macrophage responses to microbial stimuli. Repeated exposure to lipopolysaccharide (LPS) induces endotoxin tolerance, a state in which inflammatory cytokine production is suppressed while antimicrobial functions are preserved. Although regulatory mechanisms of LPS tolerance is well established, how prior LPS exposure reshapes signaling dynamics downstream of TLR4 remains unclear. Using biosensors and live-cell imaging, we quantified ERK and NF-κB signaling in RAW264.7 macrophages during LPS tolerance. Tolerized macrophages produced less TNF-α and IL-6 and showed reduced ERK and NF-κB activity, with lower amplitudes and areas under the curve than cells receiving a single LPS stimulation. Both pathways also displayed delayed activation, reflected by a prolonged time to first peak. Inhibition experiments revealed bidirectional crosstalk, as blocking ERK altered NF-κB signaling and NF-κB inhibition suppressed ERK dynamics. These findings show that LPS tolerance involves coordinated changes in the strength and timing of ERK and NF-κB signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.